# Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor

> **NCT03793556** · NA · COMPLETED · sponsor: **SOFAR S.p.A.** · enrollment: 72 (actual)

## Conditions studied

- Gastro-oesophageal Reflux Disease

## Interventions

- **DEVICE:** GERDOFF® + Omeprazole
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT03793556
- **Lead sponsor:** SOFAR S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-05
- **Primary completion:** 2018-09-20
- **Final completion:** 2018-12-11
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03793556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03793556, "Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03793556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*